In my last post I discussed the possibility of participating in a clinical trial. Well, it happened today!
I will get the technical details out of the way: –
Trial Title – Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer
Short Title – A study to determine how often DNA Repair Defects are found in Men with Advanced Prostate Cancer
Astute readers may wonder at the point of the “short” title!
Anyway, my layman’s translation is “We take your blood and tell you if the cancer is hereditary”. Maybe not 100% accurate, but it works for me.
So….what does it all mean?
- Up to 10,000 people worldwide (600 from Australia) will participate
- The trial sponsor is Janssen Research and Development (part of Johnson and Johnson)
- Recent data suggests that tumours caused by hereditary gene defects may be more sensitive to certain drugs
- If I have hereditary gene defects I may qualify for potential future clinical trials for a treatment targeting these tumours
Apparently there have been successes in this area with ovarian cancer. It is not a cure, but another potential treatment to delay progress of the disease.
It may lead nowhere, but it will be nice to know if my cancer was home grown or hereditary. And it is always good to do something constructive.
I gave blood today and that is all that is involved. I will get the results in my next onco appointment in July.
Good health and happiness to all. Cheers, Phil